Identification of a chemotherapy resistance factor in breast cancer patients
Scientists have identified low expression of methylation-controlled J protein (MCJ) as a marker of poor response to chemotherapy.
Today's Tech News and Opinion
Today's Tech News and Opinion
Scientists have identified low expression of methylation-controlled J protein (MCJ) as a marker of poor response to chemotherapy.
Leave a Reply